首页> 外文期刊>Oncology Research >In vitro antitumor SAR of threo/cis/threo/cis/erythro bis-THF acetogenins: correlations with their inhibition of mitochondrial Complex I.
【24h】

In vitro antitumor SAR of threo/cis/threo/cis/erythro bis-THF acetogenins: correlations with their inhibition of mitochondrial Complex I.

机译:苏式/顺式/苏式/顺式/赤型双-THF乙酰原素的体外抗肿瘤SAR:与它们对线粒体复合体I的抑制作用相关。

获取原文
获取原文并翻译 | 示例
       

摘要

Annonaceous acetogenins (ACG) are a large family of natural products that have been described as the most potent in vitro inhibitors of the mitochondrial respiratory chain Complex I. During the last two decades a large number of related structures have been discovered, increasing the number of members of this family. The large diversity of structural moieties and the general trends observed for inhibiting both growth of tumor cell lines and mitochondrial respiratory chain activity have resulted in the classification of these compounds into several structural groups according to their potency. Among them, the adjacent bis-tetrahydrofuranic acetogenins (bis-THF ACG) with a threo/cis/threo/cis/erythro relative configuration, have been described as the most potent subgroup, the prototypical member of which, rolliniastatin-1, was originally isolated from Rollinia membaranacea seeds. In this report we describe the different structure-activity relationships (SAR) observed for some natural ACG and semisynthetic derivatives as growth inhibitors of human tumor breast, lung, liver, and colon cell lines. All the compounds assayed showed potencies in the micromolar range. Trends observed in the cytotoxicity assay have been compared with previous data reported for these compounds as inhibitors of mitochondrial respiratory chain.
机译:丙酮酸单环生成素(ACG)是一大类天然产物,已被描述为线粒体呼吸链复合体I的最有效的体外抑制剂。在过去的二十年中,已经发现了许多相关的结构,从而增加了这个家庭的成员。结构部分的多样性以及抑制肿瘤细胞系生长和线粒体呼吸链活性的普遍趋势已导致根据其功效将这些化合物分为几个结构组。其中,相邻的具有苏式/顺式/苏式/顺式/顺式/赤型相对构型的双-四氢呋喃产乙酸菌素(双-THF ACG)被描述为最有效的亚组,其原型成员rolliniastatin-1最初是分离自Rollinia membaranacea种子。在本报告中,我们描述了观察到的一些天然ACG和半合成衍生物作为人类肿瘤乳腺,肺,肝和结肠细胞系生长抑制剂的不同构效关系(SAR)。所有测定的化合物均显示在微摩尔范围内的效力。已经将细胞毒性试验中观察到的趋势与这些化合物作为线粒体呼吸链抑制剂的先前报道数据进行了比较。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号